SCHEMBL8238641

SCHEMBL8238641

BN1CCN(C(=O)c2ccn(-c3ccccc3NC(=O)CCCC)c2-c2ccccc2)C(Cc2ccccc2)C1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
LMNA P02545 2/20 0.41
PLA2G1B P04054 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
SOAT1 P35610 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CA1 P00915 7/20 0.35
CA2 P00918 7/20 0.35
CA4 P22748 7/20 0.35
CA9 Q16790 7/20 0.35
CETP P11597 1/20 0.34
POLB P06746 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3495109 0.91 TSHR (0.41) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL3492306 0.88 TSHR (0.44) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL13340197 0.86 HDAC1 (0.41) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL3493260 0.86 TSHR (0.45) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL8237483 0.84 TSHR (0.42) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL3493927 0.83 CA1 (0.39) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL3494534 0.82 CA1 (0.36) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL8231116 0.81 TSHR (0.43) TSHRALDH1A1CA1CA2CA4
SCHEMBL3493714 0.80 HDAC1 (0.41) TSHRLMNAPLA2G1BKMT2ANPSR1
SCHEMBL3492703 0.80 CA1 (0.40) TSHRKMT2ASMN1; SMN2ALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007094513-A2 CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-23 WO disclosed